Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295783 · ClinicalTrials.gov registry record
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
A clinical trial of Radiation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06295783 is a study of Radiation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06295783, a study of Radiation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
Conditions Studied
Interventions
- OTHER MDASI-HN
- OTHER EORTC QLQ-C30
- OTHER EORTC HN35
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2027-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06295783
The ClinicalTrials.gov registry entry for NCT06295783 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation appearing as the primary indexed condition, and to 3 interventions - of which MDASI-HN is the first listed.
NCT06295783 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06295783 about?
NCT06295783 is a clinical study titled "Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect". To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
What is the current status of trial NCT06295783?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2024-06-10. Estimated completion is 2027-02-01.
What conditions does trial NCT06295783 study?
This clinical trial studies the following conditions: Radiation.
What interventions are being tested in trial NCT06295783?
The interventions under investigation include: MDASI-HN (OTHER), EORTC QLQ-C30 (OTHER), EORTC HN35 (OTHER).
Who is sponsoring clinical trial NCT06295783?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295783 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.